HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

N-(5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl)-N-methyl-2-(4-(2-pyridinyl)phenyl)acetamide

HCID 491941
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
348086-71-5
Standard SMILES
Cc1nc(N(C)C(=O)Cc2ccc(-c3ccccn3)cc2)sc1S(N)(=O)=O
InChIKey
IVZKZONQVYTCKC-UHFFFAOYSA-N
Molecular formula
C18H18N4O3S2
Average molar mass
402.5 g/mol
Monoisotopic mass
402.0820328

Overview

Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.

Names & identifiers

Preferred name
N-(5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl)-N-methyl-2-(4-(2-pyridinyl)phenyl)acetamide
IUPAC
N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide
English name
BAY-57-1293
Molecular formula
C18H18N4O3S2
Molecular weight
402.49

Names & synonyms

Pritelivir348086-71-5BAY-57-1293AIC-316N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide07HQ1TJ4JEAIC090093AIC-090093DTXSID70188344n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamideN-(5-(Aminiosulfonyl)-4-methyl-1,3-thiazol-2-yl)-N-methyl-2-(4-(2-pyridinyl)phenyl)acetamideBenzeneacetamide, N-(5-(aminosulfonyl)-4-methyl-2-thiazolyl)-N-methyl-4-(2-pyridinyl)-
Show more names
CS-857Pritelivir baseBAY571293(Pritelivir)Pritelivir,BAY-57-1293Pritelivir, 10 mM in DMSO
Benzeneacetamide, N-[5-(aminosulfonyl)-4-methyl-2-thiazolyl]-N-methyl-4-(2-pyridinyl)-N-(5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL)-N-METHYL-2-(4-(2-PYRIDINYL)PHENYL)ACETAMIDEpritelivirumRefChem:176034DTXCID00110835BAY 57-1293N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-(pyridin-2-yl)phenyl)acetamideAIC316

Database identifiers

CAS
348086-71-5
PubChem CID
491941
DTXSID
DTXSID70188344
ChEMBL
CHEMBL4069597
UNII
07HQ1TJ4JE
Nikkaji
J1.735.177J

Properties

Computed structural propertiesFilling in

XLogP
2.1
Topological polar surface area
143 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
7
Rotatable bonds
5
Heavy atoms
27
Formal charge
0
Complexity
617

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Boiling point
639.4 · 639.4±65.0 °C(Predicted)
Density
1.396 · 1.396±0.06 g/cm3(Predicted)
storage temp.
2 · 2-8°C(protect from light)
solubility
2 O; · insoluble in H2O; insoluble in EtOH; ≥13.9 mg/mL in DMSO
form
solid
pka
9.31 · 9.31±0.60(Predicted)
color
White to off-white
InChI
InChI=1S/C18H18N4O3S2/c1-12-17(27(19,24)25)26-18(21-12)22(2)16(23)11-13-6-8-14(9-7-13)15-5-3-4-10-20-15/h3-10H,11H2,1-2H3,(H2,19,24,25)
InChIKey
IVZKZONQVYTCKC-UHFFFAOYSA-N
SMILES
C1(CC(N(C2=NC(C)=C(S(N)(=O)=O)S2)C)=O)=CC=C(C2=NC=CC=C2)C=C1
FDA UNII
7 HQ1TJ4JE · 07HQ1TJ4JE
NCI Drug Dictionary
pritelivir
UNSPSC Code
51111800 · 51111800
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P264-P270-P271-P280-P301+P312-P330-P302+P352-P321-P304+P340-P305+P351+P338-P332+P313-P362+P364-P337+P313-P403+P233-P405-P501
WGK Germany
3 · WGK 3
Storage Class
11 · 11 - Combustible Solids

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
WGK 3
Signal word
Warning
Symbol(GHS)
GHS07
Storage Class
11 - Combustible Solids
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P264-P270-P271-P280-P301+P312-P330-P302+P352-P321-P304+P340-P305+P351+P338-P332+P313-P362+P364-P337+P313-P403+P233-P405-P501

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.

Applications

UsesBAY 57-1293 is a potent inhibitor of herpes simplex virus (HSV) that target the virus helicase primase complex.

Related reactions

2 records
New reaction record
HRID 1362785 reaction equation
HRID 1362785As product
HRID 2213531 reaction equation
HRID 2213531As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes